Latest filing published 01 Oct 2026 for 케어젠. Read the official filing
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of 정용지 in 케어젠, where the filings describe the role as chief executive. In total, 49 filings cover trades dated from 15 September 2022 to 1 October 2026.
On the market, this insider has only ever bought: 43 purchases, €646k in total. The totals exclude 37 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 10 purchases and no sales.
Half of the purchases are above €117k and half below. Scaled by market value, the purchases weigh a median 0.0072% of market cap (sample: 6 purchases). Of 38 purchases, 5 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 6 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -48.2%. These figures describe past trades and do not predict future prices.
Most recently, on 1 October 2026, the filings show a transaction in 케어젠. The clock since the last published purchase (10 July 2026) now reads 100 days. The median gap between a trade and its publication by DART (FSS) is 1 day. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 49 declarations